Works matching IS 15674215 AND DT 2022 AND VI 24 AND IP 2

Results: 25
    1

    Reply to 'Epicardial adipose tissue: does it mediate the cardio-protective effects of sodium-glucose co-transporter 2 inhibitors in subjects with heart failure?' Letter regarding the article 'Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure'

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 401, doi. 10.1002/ejhf.2423
    By:
    • De Biase, Nicolò;
    • Del Punta, Lavinia;
    • Pugliese, Nicola Riccardo
    Publication type:
    Article
    2
    3

    Epicardial adipose tissue: does it mediate the cardio-protective effects of sodium-glucose co-transporter 2 inhibitors in patients with heart failure? Letter regarding the article 'Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure'

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 400, doi. 10.1002/ejhf.2412
    By:
    • Doumas, Michael;
    • Patoulias, Dimitrios;
    • Papadopoulos, Christodoulos
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    Worsening renal function in acute heart failure in the context of diuretic response.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 365, doi. 10.1002/ejhf.2384
    By:
    • Emmens, Johanna E.;
    • Maaten, Jozine M. ter;
    • Yuya Matsue;
    • Figarska, Sylwia M.;
    • Sama, Iziah E.;
    • Cotter, Gad;
    • Cleland, John G. F.;
    • Davison, Beth A.;
    • Felker, G. Michael;
    • Givertz, Michael M.;
    • Greenberg, Barry;
    • Pang, Peter S.;
    • Severin, Thomas;
    • Gimpelewicz, Claudio;
    • Metra, Marco;
    • Voors, Adriaan A.;
    • Teerlink, John R.
    Publication type:
    Article
    10
    11
    12
    13
    14

    Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: overview and the central role for catecholamines and sympathetic nervous system

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 257, doi. 10.1002/ejhf.2400
    By:
    • Omerovic, Elmir;
    • Citro, Rodolfo;
    • Bossone, Eduardo;
    • Redfors, Bjorn;
    • Backs, Johannes;
    • Bruns, Bastian;
    • Ciccarelli, Michele;
    • Couch, Liam S.;
    • Dawson, Dana;
    • Grassi, Guido;
    • Iacoviello, Massimo;
    • Parodi, Guido;
    • Schneider, Birke;
    • Templin, Christian;
    • Ghadri, Jelena R.;
    • Thum, Thomas;
    • Chioncel, Ovidiu;
    • Tocchetti, C. Gabriele;
    • van der Velden, Jolanda;
    • Heymans, Stephane
    Publication type:
    Article
    15
    16
    17
    18
    19

    Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 274, doi. 10.1002/ejhf.2368
    By:
    • Omerovic, Elmir;
    • Citro, Rodolfo;
    • Bossone, Eduardo;
    • Redfors, Bjorn;
    • Backs, Johannes;
    • Bruns, Bastian;
    • Ciccarelli, Michele;
    • Couch, Liam S.;
    • Dawson, Dana;
    • Grassi, Guido;
    • Iacoviello, Massimo;
    • Parodi, Guido;
    • Schneider, Birke;
    • Templin, Christian;
    • Ghadri, Jelena R.;
    • Thum, Thomas;
    • Chioncel, Ovidiu;
    • Tocchetti, C. Gabriele;
    • van der Velden, Jolanda;
    • Heymans, Stephane
    Publication type:
    Article
    20

    Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial.

    Published in:
    European Journal of Heart Failure. Supplements, 2022, v. 24, n. 2, p. 321, doi. 10.1002/ejhf.2394
    By:
    • Ravassa, Susana;
    • López, Begoña;
    • Ferreira, João Pedro;
    • Girerd, Nicolas;
    • Bozec, Erwan;
    • Pellicori, Pierpaolo;
    • Mariottoni, Beatrice;
    • Cosmi, Franco;
    • Hazebroek, Mark;
    • Verdonschot, Job A. J.;
    • Cuthbert, Joe;
    • Petutschnigg, Johannes;
    • Moreno, María U.;
    • Heymans, Stephane;
    • Staessen, Jan A.;
    • Pieske, Burkert;
    • Edelmann, Frank;
    • Clark, Andrew L.;
    • Cleland, John G. F.;
    • Zannad, Faiez
    Publication type:
    Article
    21
    22
    23
    24
    25